Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease

Completed · Phase 2 · Has a placebo group

Conditions studied: Cardiovascular Disease, Chronic Kidney Disease

In brief

The goal of this proposal is to investigate the potential for ACE-inhibitors (ACE-I)(drugs primarily used to treat hypertension or congestive heart failure) to prevent or delay cardiovascular disease (CVD) in older adults with chronic kidney disease (CKD) by examining their impact on aortic stiffness in people with stage 3 CKD in a randomized, controlled study.

Key facts

Study ID
NCT00874432
Run by
University of Wisconsin, Madison
People needed
43
Starts
2009-01-01
Expected to finish
2011-12-01
Last updated by the study team
2020-10-27

Who can join

Age: 60 and older, up to 89. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.